medmix publishes a midyear report as well as an annual report.
Ad hoc announcement pursuant to Art. 53 LR
medmix announces negotiations for the sale of its Polish entity, following its decision to stop production in Wroclaw, Poland. The company revises its outlook for FY 2022, reflecting the impact of mitigating sanctions in Poland, ongoing inflationary pressures, and mix.
In line with its local for local growth strategy in China, medmix has signed an investment agreement to acquire a majority stake in Guangdong Qiaoyi Plastic Co. LTD, a beauty manufacturing business in Shantou.
medmix, global leader in high-precision delivery devices, won the prestigious Good Design™ Award 2022 in the Medical category for PiccoJect™, the autoinjector from medmix Drug Delivery (Haselmeier™). PiccoJect™ is a disposable two-step autoinjector designed for subcutaneous injection.
medmix works with a UK distributor to defend trademark rights and remove counterfeit products imitating its COXTM handheld sealant and adhesive dispensers from sale. Having successfully identified an illegal supply route, medmix now supports the distributor by providing an OEM supply of genuine, high-quality dispensers.
Ad hoc announcement pursuant to Art. 53 LR
Stuttgart – medmix Drug Delivery (Haselmeier) and AARDEX Group announced today a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and Hardware ecosystem.
medmix Switzerland Ltd is the global market leader in the design and production of manual, pneumatic and battery handheld sealant and adhesive applicators. In recent years nearly identical copies of such dispensers have been discovered on the market. These slavish imitations from other producers are not made under the strict quality control measures of medmix and therefore are not protected by its guarantee.
In line with its focus on establishing additional, cost-competitive manufacturing capacities, medmix has signed a business acquisition agreement for the entire plastics business of Universal de Suministros, S.L., Spain ("Universal").
Ad hoc announcement pursuant to Art. 53 LR
MIDYEAR 2022 HIGHLIGHTS
As a part of medmix, a global leader in high-precision delivery devices, GEKA (medmix Beauty) is releasing its first Sustainability report, outlining the commitment to and progress towards the company’s sustainability goals.
Ad hoc announcement pursuant to Art. 53 LR
Ad hoc announcement pursuant to Art. 53 LR
medmix is relocating production to other countries following an initial negative decision on sanctions unilaterally introduced by Poland. It is medmix’ firm belief that the sanctions against its entity in Poland are erroneous. The company continues its appeal process, with the full support of the Swiss government administration. medmix is not affected by any other sanctions and is free to develop its business globally.